Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT04031521

Near Infrared Spectroscopy in Sickle Cell Pediatric Patients

Near-infrared Spectroscopy in Sickle Cell Pediatric Patients During Pain Crisis and After Recovery

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
Children's National Research Institute · Academic / Other
Sex
All
Age
6 Years – 21 Years
Healthy volunteers
Not accepted

Summary

Endothelial dysfunction contributes to vaso-occlusion and acute pain in sickle cell disease. Near infrared spectroscopy (NIRS) technology can measure tissue oxygenation and endothelial function. The main objective of this study is to study the natural history of tissue muscle oxygenation using NIRS in pediatric sickle cell subjects experiencing acute pain and pediatric sickle cell patients in steady-state.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTNear infrared spectroscopyNIRS is an emerging technology for measuring tissue oxygenation and endothelial function. NIRS light can penetrate through biological tissues, including skin, bone, and muscle. Similar to other optical methods, light is applied to the region of interest and undergoes scattering and absorption before being detected by a photosensor. This technique is commonly used to assess oxygen availability and consumption in living tissues. Using different wavelengths, NIRS can differentiate between oxygenated and deoxygenated hemoglobin in blood and can measure changes in total hemoglobin concentration, using the sum of oxygenated and deoxygenated hemoglobin.

Timeline

Start date
2019-06-26
Primary completion
2023-09-03
Completion
2023-09-03
First posted
2019-07-24
Last updated
2023-09-14

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04031521. Inclusion in this directory is not an endorsement.